CVS Health Co. (NYSE:CVS – Get Free Report)’s share price fell 1.5% during trading on Wednesday after Argus lowered their price target on the stock from $100.00 to $80.00. Argus currently has a buy rating on the stock. CVS Health traded as low as $54.69 and last traded at $54.93. 3,955,369 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 11,776,579 shares. The stock had previously closed at $55.74.
Several other analysts have also issued reports on CVS. The Goldman Sachs Group dropped their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Truist Financial reiterated a “buy” rating and set a $66.00 target price (down previously from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Barclays dropped their target price on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, May 2nd. SVB Leerink reiterated a “market perform” rating and set a $60.00 target price (down previously from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Finally, Mizuho lowered their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $76.75.
Read Our Latest Stock Report on CVS
Insider Activity
Institutional Investors Weigh In On CVS Health
Hedge funds have recently modified their holdings of the company. SOA Wealth Advisors LLC. raised its holdings in CVS Health by 4.9% in the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 133 shares in the last quarter. Apella Capital LLC raised its holdings in CVS Health by 4.2% in the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after purchasing an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC raised its holdings in CVS Health by 4.1% in the 4th quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after purchasing an additional 141 shares in the last quarter. WealthShield Partners LLC raised its holdings in CVS Health by 3.2% in the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after purchasing an additional 141 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC raised its holdings in CVS Health by 9.5% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 142 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Stock Down 1.5 %
The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company’s fifty day simple moving average is $71.95 and its 200 day simple moving average is $73.09. The firm has a market capitalization of $68.96 billion, a P/E ratio of 9.65, a price-to-earnings-growth ratio of 0.88 and a beta of 0.56.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.20 earnings per share. Research analysts expect that CVS Health Co. will post 7.03 EPS for the current year.
CVS Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 4.84%. CVS Health’s payout ratio is 46.75%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- Consumer Staples Stocks, Explained
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Canadian Penny Stocks: Can They Make You Rich?
- Generac Powers Ahead on the Electrification Mega-Trend
- Stock Average Calculator
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.